Top Pharmaceutical Web & App Design Agencies to Work With - August 2026
Introduction
Pharmaceutical digital products carry a constraint that reshapes how they are built. Effectively every word on screen is promotional material subject to medical, legal, and regulatory review, including interface copy, error states, and navigation labels. That means a pharmaceutical site or app cannot be iterated the way a commercial product can: each change re-enters review, so the cost of a small improvement is measured in approval cycles rather than development hours. Agencies that have not worked inside that reality design products the organization cannot maintain.
This article compares ten pharmaceutical web and app design agencies: pharma-native digital partners, regulated product engineering firms, and focused design studios, with each entry stating which. It is written for VPs of Digital, brand leads, and technology leadership at pharmaceutical and biotech organizations.
How We Selected These Firms
This ranking is published by G&CO. Health. We evaluated agencies on pharmaceutical and life sciences experience, fluency with review and compliance workflows, depth across design and engineering, accessibility practice, and evidence of delivered products rather than concepts.
We assessed firms on demonstrated pharmaceutical or regulated-industry delivery rather than general digital capability, and grouped them by the kind of problem they solve, since organizations arrive needing very different things at very different budgets. Entries state which tier a firm serves. We include ourselves at the top because pharmaceutical digital product work sits directly inside our remit, at the intersection of research, experience design, and delivery. No agency on this list has paid for placement, and no entry on this page is sponsored.
Firms Compared
The table below summarizes where each agency fits. The first four serve enterprise mandates; the last six are focused studios and specialists.
The Firms
1. G&CO. Health
Best for: Enterprise pharmaceutical organizations where a digital product has to serve the brand strategy above it and survive the review process around it.
Why it stands out: G&CO. Health brings research, experience design, and engineering into the same engagement, working with pharmaceutical organizations on web and mobile products, through G&CO. Health. Because every interface decision is also a claim subject to review, we design content structures that allow updates without resubmitting the whole product, which is what determines whether a pharmaceutical site remains maintainable a year after launch. G&CO. Health is part of G&CO., a minority business enterprise (MBE), as certified by the National Minority Supplier Development Council (NMSDC).
May not be best if: You need staff augmentation for an existing product team, or regulatory submission support for software as a medical device.
2. EVERSANA INTOUCH
Best for: Enterprise pharmaceutical organizations running digital across many brands and markets.
Why it stands out: EVERSANA INTOUCH is pharma-native rather than a general digital agency with pharmaceutical clients, and the difference shows in how it handles review. Its teams design and build around medical, legal, and regulatory workflow as a standing condition rather than an obstacle encountered per project, which matters most for organizations maintaining dozens of brand properties where review capacity is the shared constraint across all of them.
May not be best if: You are a single-product biotech, where enterprise agency economics would not be justified.
3. GlobalLogic
Best for: Medical technology and pharmaceutical organizations with device-adjacent or regulated software programs.
Why it stands out: GlobalLogic brings engineering depth in regulated and device-connected product development, including the documentation and verification practice such work requires. Where a digital product connects to a device, handles clinical data, or falls near the regulated boundary, that engineering discipline is the reason to engage a firm of this type rather than a design-led studio.
May not be best if: You are building a brand website or unregulated patient support tool, where this rigor adds cost without benefit.
4. Kin + Carta
Best for: Pharmaceutical organizations modernizing a digital estate rather than building one product.
Why it stands out: Kin + Carta combines digital strategy with product delivery for enterprises in regulated sectors, which suits organizations whose problem is a fragmented set of legacy properties rather than a single new build. Consolidating dozens of brand sites onto shared architecture is a governance and platform problem before it is a design one, and firms that treat it as design work produce consistent-looking properties on incompatible foundations.
May not be best if: You need a single focused product build, where a smaller studio would move faster at lower cost.
5. Endava
Best for: Organizations with build volume requiring several engineering teams working in parallel.
Why it stands out: Endava delivers product engineering at program scale across regulated industries, supporting concurrent workstreams against shared architecture. Where the constraint is capacity rather than specialized pharmaceutical knowledge, that matters more than domain depth, since smaller studios generally cannot run parallel delivery without the work diverging.
May not be best if: Your program is a single product with heavy pharmaceutical-specific requirements, where domain fluency matters more than capacity.
6. The STUDIO
Best for: Emerging pharmaceutical and research organizations wanting design-led HCP and patient portals. Focused studio.
Why it stands out: The STUDIO brings a design-forward approach to healthcare communications, working on UX and interface design for pharmaceutical sites, prescriber portals, and patient engagement platforms. Its concentration on design craft rather than engineering scale suits organizations where the product is modest in complexity and the differentiation is how it feels to use.
May not be best if: You need substantial engineering capacity, systems integration, or regulated device software capability.
7. Clarity Quest
Best for: Growth-stage biotech and medtech companies building digital products alongside commercial traction. Focused specialist.
Why it stands out: Clarity Quest works across biotech, medtech, and pharmaceutical clients on websites, patient applications, and provider platforms, combining technical execution with marketing integration. For companies where digital investment has to demonstrate commercial return within a funding cycle, connecting the build to acquisition and conversion is what makes it defensible internally.
May not be best if: You are an enterprise pharmaceutical organization needing multi-brand platform governance.
8. Brightscout
Best for: Life science companies building brand identity and digital product at the same time. Focused studio.
Why it stands out: Brightscout works across brand and digital product for technology and life science clients, taking identity and build through one team. For companies establishing a brand and its first substantial digital presence simultaneously, keeping both with one group avoids the incoherence that separate engagements reliably produce.
May not be best if: You have an established brand system and need engineering capacity or regulated software capability.
9. Mindgrub
Best for: Organizations with defined application requirements needing custom engineering. Focused specialist.
Why it stands out: Mindgrub builds custom applications and handles integration work for clients including regulated organizations. Where requirements are settled and the need is competent execution rather than product definition, engaging a firm priced for delivery rather than strategy is the sensible economic choice.
May not be best if: You need product strategy, pharmaceutical review fluency, or experience design leadership.
10. Unleashed Technologies
Best for: Brands managing large content estates across many properties. Focused specialist.
Why it stands out: Unleashed Technologies works on content platform architecture and ongoing site delivery, which is relevant to pharmaceutical organizations whose real problem is maintaining many properties rather than launching one. Content architecture determines whether a brand team can update approved copy independently or must route every change through developers, and that decision governs maintenance cost for years.
May not be best if: You need experience design leadership, product strategy, or regulated device software development.
%20(1).png)
Let’s kickstart the conversation and design stuff people will love.
The Retail & Consumer Index
What Is Pharmaceutical Web and App Design?
Pharmaceutical web and app design is the research, design, and engineering of digital products for pharmaceutical and biotech organizations: branded product sites, prescriber portals, patient support applications, and the platforms behind them.
What separates it from general digital work is that the content is regulated. Product claims, safety information, and in many jurisdictions the balance between them are governed by promotional rules, and the material must be reviewed before publication. Interface copy is not exempt. That single condition changes the design problem: products must be built so that regulated content can be updated within its own approval cycle without rebuilding the surrounding experience.
How Does Pharmaceutical Web and App Design Work?
Projects run through discovery, definition, design, build, review, testing, and release. The review step sits between design and release rather than after it, and applies to content and often to the interface presenting it.
The consequence agencies most often miss is architectural. If approved content is embedded in page templates, every copy change becomes a development task and a fresh review of the whole page. If it is separated into structured, individually approvable components, a safety update can move through review and go live without touching anything else. That decision is taken early, is invisible in a design review, and determines whether the product can be maintained affordably. It is worth asking about explicitly during selection, since it rarely appears in a proposal.
What Is a Pharmaceutical Web and App Design Agency?
A pharmaceutical web and app design agency designs and builds digital products for pharmaceutical organizations, holding the review, accessibility, and privacy expertise the sector requires alongside general product capability.
The category contains tiers that are not substitutable. Pharma-native digital agencies are structured around review workflow across many brands. Regulated engineering firms build device-adjacent and clinical-data products. Transformation firms consolidate fragmented estates. Design studios produce craft-led products at modest complexity. Delivery specialists execute against defined requirements at lower cost. These differ substantially in price, and comparing them as though they were bidding for the same work is the common procurement error here.
What Services Do Pharmaceutical Design Agencies Provide?
Product strategy and definition
Establishing what to build and for which audience before engineering starts, which in pharmaceuticals also means establishing what can be claimed.
Experience and interface design
Designing for prescribers working between appointments and patients managing a condition, whose available attention differs sharply from general consumers.
Content architecture for regulated material
Structuring approved content so it can be updated within its own review cycle. The decision that most affects long-term maintenance cost.
Front-end and back-end engineering
Building to pharmaceutical security and privacy requirements, including consent handling and adverse event reporting pathways where applicable.
Accessibility and inclusive design
Meeting legal accessibility standards and designing for low health literacy, which describes a substantial share of patient users.
Review workflow integration
Connecting the build process to medical, legal, and regulatory review so approvals are tracked rather than managed in email.
Integration with CRM and marketing platforms
Connecting digital properties to the systems holding prescriber and patient relationships, so behavior in one is visible in the other.
Maintenance and content operations
Ongoing updates, security patching, and content changes after launch, usually under a separate agreement and frequently underestimated.
How Long Does a Pharmaceutical Digital Project Take?
A branded product website typically runs four to eight months including review. A prescriber portal or patient support application generally runs eight to fourteen months. A multi-brand platform consolidation runs twelve to twenty-four months, delivered in phases by brand or market.
Review governs the timeline more than development does, and it compounds in a way teams underestimate: content, interface copy, and functional changes may each require their own cycle, and cycles do not run in parallel. Organizations that book review capacity at the start rather than submitting into a queue consistently finish earlier. Asking an agency how it sequences review is a reliable way to distinguish those with real pharmaceutical experience from those with healthcare-adjacent experience.
How Pharmaceutical Design Agencies Price Their Work
Fixed fee suits websites with defined scope. Time and materials suits application development where requirements evolve. Enterprise agencies often work under annual arrangements covering multiple brand properties. Maintenance and content operations are contracted separately and are frequently the larger cost over a product's life.
Rates differ substantially between pharma-native agencies and general development firms. The premium buys review fluency and content architecture that survives the approval process, which is real value on a brand property and unnecessary on an internal tool. Establishing which you are buying prevents both overpaying and, more expensively, underbuying.
The cost most often omitted is content operations after launch. Pharmaceutical properties require ongoing safety updates, label changes, and market adaptations, each carrying its own review. Budgeting for the build alone means that work arrives unfunded, and the usual outcome is a product that quietly falls out of date.
Why Hire a Pharmaceutical Design Agency?
The strongest reason is that review shapes architecture, and that connection is not obvious to teams who have not worked inside it. An agency that has maintained pharmaceutical properties through several label changes designs differently from one that has only launched them.
The second is accessibility and privacy competence. Both are legal obligations, both are frequently treated as final checks rather than design constraints, and retrofitting either is considerably more expensive than designing for it.
The third is comparative exposure. An organization builds a prescriber portal once. An agency has built many and knows which patterns clinicians actually use and which are abandoned within weeks of launch, which is judgement rather than production capability.
How to Choose the Most Reliable Pharmaceutical Design Agency
Start by establishing which tier the work needs: pharma-native, regulated engineering, transformation, design studio, or delivery specialist. The visible output of all five looks similar in a portfolio and the underlying capability does not.
Then test three things. How they structure regulated content, which determines maintenance cost for the product's whole life. Delivered pharmaceutical products rather than healthcare-adjacent concepts, since portfolios in this category frequently show work that never cleared review. And what maintenance and content operations cost afterward, because that obligation is permanent and usually unpriced at selection.
One further question separates the field. Ask what happens to this product when the label changes. An agency with a specific answer has maintained pharmaceutical properties. An agency that treats it as an edge case has only launched them.
Decision Intelligence
15 Questions to Ask Before You Hire
1. What happens to this product when our label changes?
An agency with a specific answer has maintained pharmaceutical properties. One treating it as an edge case has only launched them.
2. How will you structure regulated content so it can be updated independently?
Content embedded in templates makes every copy change a development task and a fresh review. This governs maintenance cost for years.
3. Can you show pharmaceutical products that cleared review and shipped?
Portfolios in this category frequently feature healthcare-adjacent concepts that never went through the process.
4. How do you sequence medical, legal, and regulatory review during the build?
Review cycles do not run in parallel. A firm that plans for that finishes ahead of one that submits into a queue.
5. Which tier are you: pharma-native, engineering, or design studio?
All five tiers look similar in a portfolio and differ by a large multiple in cost and capability.
6. What does maintenance and content operations cost after launch?
Safety updates, label changes, and market adaptations each carry review. Budgeted for build alone, this arrives unfunded.
7. Is accessibility a design constraint from the start or an audit at the end?
A legal obligation, and retrofitting it costs considerably more than designing for it.
8. How will prescribers or patients be involved in testing?
Portals designed without clinician input are abandoned within weeks regardless of how well they test internally.
9. How do you handle adverse event reporting pathways?
A legal requirement where patients can submit input. A firm without a defined approach creates exposure for you.
10. Which of your last three pharmaceutical projects ran over, and why?
A specific answer describes a real delivery record. A claim of none describes a sales position.
11. Who owns the code and content structure when we finish?
Ownership and handover terms vary more than buyers expect and matter most when the relationship ends.
12. How will this connect to our CRM and marketing platforms?
Integration is usually scoped last and determines whether behavior on the property is visible anywhere else.
13. Is the team that pitches the team that builds?
The most common gap in agency delivery, and the one that most affects the result.
14. What will you need from our brand, medical, legal, and IT teams?
Internal bandwidth is the usual constraint on pace and the most commonly understated line in a proposal.
15. What would make you decline this project?
An agency with a clear answer knows where it adds value. No answer means it is describing capacity, not fit.
Why Choose G&CO.
G&CO. Health is the healthcare practice of G&CO., a global strategy and experience partner working with enterprise pharmaceutical and life sciences organizations. On digital product mandates we bring research, experience design, and engineering into the same engagement: establishing what the product must do for prescribers or patients, designing against that, and structuring regulated content so the product remains maintainable once the label changes and the competitive set moves.
We are typically suited to enterprise pharmaceutical organizations building digital products alongside a brand or commercial program, where a product specified separately from the strategy it serves arrives compliant and unused. Our Acumen decision intelligence platform supplies the behavioral evidence beneath product decisions, supporting the analysis that determines what to build and for whom.
G&CO. Health is part of G&CO., a minority business enterprise (MBE), as certified by the National Minority Supplier Development Council (NMSDC). If diversity inclusion is part of your supplier process, we may be a strong fit for your enterprise.
Submit an inquiry to G&CO. Health on our contact page or click the blue Contact Us button on the bottom right of your screen.
